Elevated human dipeptidyl peptidase 4 expression reduces the susceptibility of hDPP4 transgenic mice to middle east respiratory syndrome coronavirus infection and disease

Abdullah Algaissi, Anurodh S. Agrawal, Song Han, Bihung Peng, Chuming Luo, Fang Li, Teh Sheng Chan, Robert B. Couch, Chien-Te Tseng

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background The ongoing Middle East respiratory syndrome coronavirus (MERS-CoV) infections pose threats to public health worldwide, making an understanding of MERS pathogenesis and development of effective medical countermeasures (MCMs) urgent. Methods We used homozygous (+/+) and heterozygous (+/-) human dipeptidyl peptidase 4 (hDPP4) transgenic mice to study the effect of hDPP4 on MERS-CoV infection. Specifically, we determined values of 50% lethal dose (LD 50) of MERS-CoV for the 2 strains of mice, compared and correlated their levels of soluble (s)hDPP4 expression to susceptibility, and explored recombinant (r)shDPP4 as an effective MCM for MERS infection. Results hDPP4 +/+ mice were unexpectedly more resistant than hDPP4 +/- mice to MERS-CoV infection, as judged by increased LD 50, reduced lung viral infection, attenuated morbidity and mortality, and reduced histopathology. Additionally, the resistance to MERS-CoV infection directly correlated with increased serum shDPP4 and serum virus neutralizing activity. Finally, administration of rshDPP4 led to reduced lung virus titer and histopathology. Conclusions Our studies suggest that the serum shDPP4 levels play a role in MERS pathogenesis and demonstrate a potential of rshDPP4 as a treatment option for MERS. Additionally, it offers a validated pair of Tg mice strains for characterizing the effect of shDPP4 on MERS pathogenesis.

Original languageEnglish (US)
Pages (from-to)829-835
Number of pages7
JournalJournal of Infectious Diseases
Volume219
Issue number5
DOIs
StatePublished - Feb 15 2019

Fingerprint

Coronavirus Infections
Dipeptidyl Peptidase 4
Transgenic Mice
Serum
Lung
Lethal Dose 50
Virus Diseases
Viral Load
Public Health
Middle East Respiratory Syndrome Coronavirus
Viruses
Morbidity
Mortality
Infection

Keywords

  • human DPP4
  • medical countermeasures for MERS
  • MERS pathogenesis
  • Middle East respiratory syndrome coronavirus
  • transgenic mice

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Cite this

Elevated human dipeptidyl peptidase 4 expression reduces the susceptibility of hDPP4 transgenic mice to middle east respiratory syndrome coronavirus infection and disease. / Algaissi, Abdullah; Agrawal, Anurodh S.; Han, Song; Peng, Bihung; Luo, Chuming; Li, Fang; Chan, Teh Sheng; Couch, Robert B.; Tseng, Chien-Te.

In: Journal of Infectious Diseases, Vol. 219, No. 5, 15.02.2019, p. 829-835.

Research output: Contribution to journalArticle

Algaissi, Abdullah ; Agrawal, Anurodh S. ; Han, Song ; Peng, Bihung ; Luo, Chuming ; Li, Fang ; Chan, Teh Sheng ; Couch, Robert B. ; Tseng, Chien-Te. / Elevated human dipeptidyl peptidase 4 expression reduces the susceptibility of hDPP4 transgenic mice to middle east respiratory syndrome coronavirus infection and disease. In: Journal of Infectious Diseases. 2019 ; Vol. 219, No. 5. pp. 829-835.
@article{2327175ee62642a3a709b1626bcf7a6e,
title = "Elevated human dipeptidyl peptidase 4 expression reduces the susceptibility of hDPP4 transgenic mice to middle east respiratory syndrome coronavirus infection and disease",
abstract = "Background The ongoing Middle East respiratory syndrome coronavirus (MERS-CoV) infections pose threats to public health worldwide, making an understanding of MERS pathogenesis and development of effective medical countermeasures (MCMs) urgent. Methods We used homozygous (+/+) and heterozygous (+/-) human dipeptidyl peptidase 4 (hDPP4) transgenic mice to study the effect of hDPP4 on MERS-CoV infection. Specifically, we determined values of 50{\%} lethal dose (LD 50) of MERS-CoV for the 2 strains of mice, compared and correlated their levels of soluble (s)hDPP4 expression to susceptibility, and explored recombinant (r)shDPP4 as an effective MCM for MERS infection. Results hDPP4 +/+ mice were unexpectedly more resistant than hDPP4 +/- mice to MERS-CoV infection, as judged by increased LD 50, reduced lung viral infection, attenuated morbidity and mortality, and reduced histopathology. Additionally, the resistance to MERS-CoV infection directly correlated with increased serum shDPP4 and serum virus neutralizing activity. Finally, administration of rshDPP4 led to reduced lung virus titer and histopathology. Conclusions Our studies suggest that the serum shDPP4 levels play a role in MERS pathogenesis and demonstrate a potential of rshDPP4 as a treatment option for MERS. Additionally, it offers a validated pair of Tg mice strains for characterizing the effect of shDPP4 on MERS pathogenesis.",
keywords = "human DPP4, medical countermeasures for MERS, MERS pathogenesis, Middle East respiratory syndrome coronavirus, transgenic mice",
author = "Abdullah Algaissi and Agrawal, {Anurodh S.} and Song Han and Bihung Peng and Chuming Luo and Fang Li and Chan, {Teh Sheng} and Couch, {Robert B.} and Chien-Te Tseng",
year = "2019",
month = "2",
day = "15",
doi = "10.1093/infdis/jiy574",
language = "English (US)",
volume = "219",
pages = "829--835",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Elevated human dipeptidyl peptidase 4 expression reduces the susceptibility of hDPP4 transgenic mice to middle east respiratory syndrome coronavirus infection and disease

AU - Algaissi, Abdullah

AU - Agrawal, Anurodh S.

AU - Han, Song

AU - Peng, Bihung

AU - Luo, Chuming

AU - Li, Fang

AU - Chan, Teh Sheng

AU - Couch, Robert B.

AU - Tseng, Chien-Te

PY - 2019/2/15

Y1 - 2019/2/15

N2 - Background The ongoing Middle East respiratory syndrome coronavirus (MERS-CoV) infections pose threats to public health worldwide, making an understanding of MERS pathogenesis and development of effective medical countermeasures (MCMs) urgent. Methods We used homozygous (+/+) and heterozygous (+/-) human dipeptidyl peptidase 4 (hDPP4) transgenic mice to study the effect of hDPP4 on MERS-CoV infection. Specifically, we determined values of 50% lethal dose (LD 50) of MERS-CoV for the 2 strains of mice, compared and correlated their levels of soluble (s)hDPP4 expression to susceptibility, and explored recombinant (r)shDPP4 as an effective MCM for MERS infection. Results hDPP4 +/+ mice were unexpectedly more resistant than hDPP4 +/- mice to MERS-CoV infection, as judged by increased LD 50, reduced lung viral infection, attenuated morbidity and mortality, and reduced histopathology. Additionally, the resistance to MERS-CoV infection directly correlated with increased serum shDPP4 and serum virus neutralizing activity. Finally, administration of rshDPP4 led to reduced lung virus titer and histopathology. Conclusions Our studies suggest that the serum shDPP4 levels play a role in MERS pathogenesis and demonstrate a potential of rshDPP4 as a treatment option for MERS. Additionally, it offers a validated pair of Tg mice strains for characterizing the effect of shDPP4 on MERS pathogenesis.

AB - Background The ongoing Middle East respiratory syndrome coronavirus (MERS-CoV) infections pose threats to public health worldwide, making an understanding of MERS pathogenesis and development of effective medical countermeasures (MCMs) urgent. Methods We used homozygous (+/+) and heterozygous (+/-) human dipeptidyl peptidase 4 (hDPP4) transgenic mice to study the effect of hDPP4 on MERS-CoV infection. Specifically, we determined values of 50% lethal dose (LD 50) of MERS-CoV for the 2 strains of mice, compared and correlated their levels of soluble (s)hDPP4 expression to susceptibility, and explored recombinant (r)shDPP4 as an effective MCM for MERS infection. Results hDPP4 +/+ mice were unexpectedly more resistant than hDPP4 +/- mice to MERS-CoV infection, as judged by increased LD 50, reduced lung viral infection, attenuated morbidity and mortality, and reduced histopathology. Additionally, the resistance to MERS-CoV infection directly correlated with increased serum shDPP4 and serum virus neutralizing activity. Finally, administration of rshDPP4 led to reduced lung virus titer and histopathology. Conclusions Our studies suggest that the serum shDPP4 levels play a role in MERS pathogenesis and demonstrate a potential of rshDPP4 as a treatment option for MERS. Additionally, it offers a validated pair of Tg mice strains for characterizing the effect of shDPP4 on MERS pathogenesis.

KW - human DPP4

KW - medical countermeasures for MERS

KW - MERS pathogenesis

KW - Middle East respiratory syndrome coronavirus

KW - transgenic mice

UR - http://www.scopus.com/inward/record.url?scp=85061576560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061576560&partnerID=8YFLogxK

U2 - 10.1093/infdis/jiy574

DO - 10.1093/infdis/jiy574

M3 - Article

VL - 219

SP - 829

EP - 835

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 5

ER -